{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:11:03Z","timestamp":1790082663058,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The great majority of sporadic vestibular schwannomas (VSs) are due to the inactivation of the <jats:italic>NF2<\/jats:italic> gene. In this study, we found age-dependent differences in the clinical parameters of sporadic VSs. Young patients were characterized by progressive tumour behaviours, including earlier onset of initial symptoms, shorter symptom duration and larger tumour size. An increased rate of \u201ctwo-hits\u201d of both <jats:italic>NF2<\/jats:italic> alleles, usually by mutation and allelic loss, was observed in young cases compared to older, and this correlated with the loss of protein and mRNA expression. In contrast, the tumours with a single mutation (referred to as \u2018one-hit\u2019) exhibited obvious expression levels. Moreover, a mixture of merlin-expressing tumour cells and non-expressing tumour cells was observed in \u2018one-hit\u2019 schwannomas, suggesting that a subset of \u2018one-hit\u2019 tumour cells was present in these tumours. To mimic the growth promoting effects by the second hit, we performed lentivirus-mediated <jats:italic>NF2<\/jats:italic> knockdown in the \u2018one-hit\u2019 schwannoma cultures. Following the loss of <jats:italic>NF2<\/jats:italic> expression, schwannoma cultures demonstrated increased proliferation rates. Above all, we have identified a correlation between the <jats:italic>NF2<\/jats:italic> status and the growth patterns of sporadic VSs. The treatment decision-making, microsurgery or \u201cwait and scan\u201d strategy, should be carried out according to the tumour\u2019s genetic background.<\/jats:p>","DOI":"10.1038\/s41598-017-05769-0","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T11:59:13Z","timestamp":1499687953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns"],"prefix":"10.1038","volume":"7","author":[{"given":"Hongsai","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hantao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"5769_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","volume":"26","author":"DG Evans","year":"2005","unstructured":"Evans, D. G. et al. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol. Neurotol. \n                           26, 93\u201397 (2005).","journal-title":"Otol. Neurotol."},{"key":"5769_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/00005072-199303000-00002","volume":"52","author":"RA Sobel","year":"1993","unstructured":"Sobel, R. A. Vestibular (acoustic) schwannomas: histologic features in neurofibromatosis 2 and in unilateral cases. J. Neuropathol. Exp. Neurol. \n                           52, 106\u2013113 (1993).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"5769_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau, G. A. et al. Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2. Nature. \n                           363, 515\u2013521 (1993).","journal-title":"Nature."},{"key":"5769_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/35101031","volume":"1","author":"AG Knudson","year":"2001","unstructured":"Knudson, A. G. Two hits (more or less) to cancer. Nat. Rev. Cancer. \n                           1, 157\u2013162 (2001).","journal-title":"Nat. Rev. Cancer."},{"key":"5769_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/ddu414","volume":"24","author":"JR Gehlhausen","year":"2015","unstructured":"Gehlhausen, J. R. et al. A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation. Hum. Mol. Genet. \n                           24, 1\u20138 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"5769_CR6","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","volume":"14","author":"M Giovannini","year":"2000","unstructured":"Giovannini, M. et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes. Dev. \n                           14, 1617\u20131630 (2000).","journal-title":"Genes. Dev."},{"key":"5769_CR7","doi-asserted-by":"publisher","first-page":"6216","DOI":"10.1038\/onc.2010.363","volume":"29","author":"KD Hadfield","year":"2010","unstructured":"Hadfield, K. D. et al. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas. Oncogene. \n                           29, 6216\u20136221 (2010).","journal-title":"Oncogene."},{"key":"5769_CR8","doi-asserted-by":"publisher","unstructured":"Lee, J. D., Kwon, T. J., Kim, U. K. & Lee, W. S. Genetic and Epigenetic Alterations of the NF2 Gene in Sporadic Vestibular Schwannomas. PLoS One. 7, e30418; doi:10.1371\/journal.pone.0030418 (2012).","DOI":"10.1371\/journal.pone.0030418"},{"key":"5769_CR9","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1097\/MAO.0b013e318298ac79","volume":"34","author":"L Lassaletta","year":"2013","unstructured":"Lassaletta, L. et al. NF2 Genetic Alterations in Sporadic Vestibular Schwannomas: Clinical Implications. Otol. Neurotol. \n                           34, 1355\u20131361 (2013).","journal-title":"Otol. Neurotol."},{"key":"5769_CR10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3892\/ijo.2013.1798","volume":"42","author":"M Torres-Martin","year":"2013","unstructured":"Torres-Martin, M. et al. Microarray analysis of gene expression in vestibular schwannomas reveals SPP1\/MET signaling pathway and androgen receptor deregulation. Int. J. Oncol. \n                           42, 848\u2013862 (2013).","journal-title":"Int. J. Oncol."},{"key":"5769_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11060-004-5176-3","volume":"73","author":"LG Bian","year":"2005","unstructured":"Bian, L. G. et al. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People\u2019s Republic of China. J. Neurooncol. \n                           73, 253\u2013260 (2005).","journal-title":"J. Neurooncol."},{"key":"5769_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/MLG.0b013e3181566594","volume":"118","author":"J L\u00fc","year":"2008","unstructured":"L\u00fc, J., Zou, J., Wu, H. & Cai, L. Compensative Shuttling of Merlin to Phosphorylation on Serine 518 in Vestibular Schwannoma. Laryngoscope. \n                           118, 169\u2013174 (2008).","journal-title":"Laryngoscope."},{"key":"5769_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neuroscience.2010.06.051","volume":"170","author":"H Wu","year":"2010","unstructured":"Wu, H. et al. Involvement of p21 (waf1) in merlin deficient sporadic vestibular schwannomas. Neuroscience. \n                           170, 149\u2013155 (2010).","journal-title":"Neuroscience."},{"key":"5769_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11010-008-0014-0","volume":"324","author":"Z Wang","year":"2009","unstructured":"Wang, Z., Lu, Y., Tang, J., Wang, H. & Wu, H. The phosphorylation status of merlin in sporadic vestibular Schwannomas. Mol. Cell. Biochem. \n                           324, 201\u2013206 (2009).","journal-title":"Mol. Cell. Biochem."},{"key":"5769_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11010-014-2011-9","volume":"392","author":"H Chen","year":"2014","unstructured":"Chen, H. et al. The role of NF2 gene mutations and pathogenesis-related proteins in sporadic vestibular schwannomas in young individuals. Mol. Cell. Biochem. \n                           392, 145\u2013152 (2014).","journal-title":"Mol. Cell. Biochem."},{"key":"5769_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1017\/S0022215113001266","volume":"127","author":"X Huang","year":"2013","unstructured":"Huang, X., Caye-Thomasen, P. & Stangerup, S. E. Spontaneous tumor shrinkage in 1261 observed patients with sporadic vestibular schwannoma. J. Laryngol. Otol. \n                           127, 739\u2013743 (2013).","journal-title":"J. Laryngol. Otol."},{"key":"5769_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00129492-200606000-00018","volume":"27","author":"SE Stangerup","year":"2006","unstructured":"Stangerup, S. E., Caye-Thomasen, P., Tos, M. & Thomsen, J. The natural history of vestibular schwannoma. Otol. Neurotol. \n                           27, 547\u2013552 (2006).","journal-title":"Otol. Neurotol."},{"key":"5769_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00381-007-0308-7","volume":"23","author":"MJ Mirzayan","year":"2007","unstructured":"Mirzayan, M. J. et al. Management of vestibular schwannomas in young patients-comparison of clinical features and outcome with adult patients. Childs. Nerv. Syst \n                           23, 891\u2013895 (2007).","journal-title":"Nerv. Syst"},{"key":"5769_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/gim.2013.114","volume":"16","author":"Z Zhang","year":"2014","unstructured":"Zhang, Z. et al. Mutation spectrum and differential gene expression in cystic and solid vestibular schwannoma. Genet. Med. \n                           16, 264\u2013270 (2014).","journal-title":"Genet. Med."},{"key":"5769_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-4-16","volume":"4","author":"DG Evans","year":"2009","unstructured":"Evans, D. G. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet. J. Rare. Dis. \n                           4, 16, doi:10.1186\/1750-1172-4-16 (2009).","journal-title":"Orphanet. J. Rare. Dis."},{"key":"5769_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/humu.20317","volume":"27","author":"ME Baser","year":"2006","unstructured":"Baser, M. E. & Contributors to the International NF2 Mutation Database. The Distribution of Constitutional and Somatic Mutations in the Neurofibromatosis 2 Gene. Hum. Mutat. \n                           27, 297\u2013306 (2006).","journal-title":"Hum. Mutat."},{"key":"5769_CR22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/jmg.2004.027953","volume":"42","author":"DG Evans","year":"2005","unstructured":"Evans, D. G., Maher, E. R. & Baser, M. E. Age-related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms. J. Med. Genet. \n                           42, 630\u2013632 (2005).","journal-title":"J. Med. Genet."},{"key":"5769_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ng1129","volume":"33","author":"M O\u2019Driscoll","year":"2003","unstructured":"O\u2019Driscoll, M., Ruiz-Perez, V. L., Woods, C. G., Jeggo, P. A. & Goodship, J. A. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. \n                           33, 497\u2013501 (2003).","journal-title":"Nat.Genet."},{"key":"5769_CR24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/MCB.01139-07","volume":"28","author":"BK Cole","year":"2008","unstructured":"Cole, B. K., Curto, M., Chan, A. W. & McClatchey, A. I. Localization to the cortical cytoskeleton is necessary for Nf2\/merlin-dependent epidermal growth factor receptor silencing. Mol. Cell. Biol. \n                           28, 1274\u20131284 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"5769_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1083\/jcb.200703010","volume":"177","author":"M Curto","year":"2007","unstructured":"Curto, M., Cole, B. K., Lallemand, D., Liu, C. H. & McClatchey, A. I. Contact dependent inhibition of EGFR signaling by Nf2\/merlin. J. Cell. Biol. \n                           177, 893\u2013903 (2007).","journal-title":"J. Cell. Biol."},{"key":"5769_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/gte.2004.8.368","volume":"8","author":"AJ Wallace","year":"2004","unstructured":"Wallace, A. J., Watson, C. J., Oward, E., Evans, D. G. & Elles, R. G. Mutation Scanning of the NF2 Gene: An Improved Service Based on Meta-PCR\/Sequencing, Dosage Analysis, and Loss of Heterozygosity Analysis. Genet. Test. \n                           8, 368\u2013380 (2004).","journal-title":"Genet. Test."},{"key":"5769_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cell.2010.01.029","volume":"140","author":"W Li","year":"2010","unstructured":"Li, W. et al. Merlin\/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell. \n                           140, 477\u2013490 (2010).","journal-title":"Cell."},{"key":"5769_CR28","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/onc.2008.427","volume":"28","author":"D Lallemand","year":"2009","unstructured":"Lallemand, D. et al. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. Oncogene. \n                           28, 854\u2013865 (2009).","journal-title":"Oncogene."},{"key":"5769_CR29","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1101\/gad.1054603","volume":"17","author":"D Lallemand","year":"2003","unstructured":"Lallemand, D., Curto, M., Saotome, I., Giovannini, M. & McClatchey, A. I. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes. Dev. \n                           17, 1090\u20131100 (2003).","journal-title":"Genes. Dev."},{"key":"5769_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/MAO.0b013e3181d2777f","volume":"31","author":"Z Ahmad","year":"2010","unstructured":"Ahmad, Z. et al. Merlin Knockdown in human Schwann cells: Clues to Vestibular Schwannoma Tumorigenesis. Otol. Neurotol. \n                           31, 460\u2013466 (2010).","journal-title":"Otol. Neurotol."},{"key":"5769_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/hmg\/11.1.69","volume":"11","author":"KM Schulze","year":"2002","unstructured":"Schulze, K. M., Hanemann, C. O., M\u00fcller, H. W. & Hanenberg, H. Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis. Hum. Mol. Genet. \n                           11, 69\u201376 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"5769_CR32","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","volume":"25","author":"X Guang-Hui","year":"2005","unstructured":"Guang-Hui, X. et al. The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression. Mol. Cell. Biol. \n                           25, 2384\u20132394 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"5769_CR33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jmg.37.12.897","volume":"37","author":"DG Evans","year":"2000","unstructured":"Evans, D. G., Sainio, M. & Baser, M. E. Neurofibromatosis type 2. J. Med. Genet \n                           37, 897\u2013904 (2000).","journal-title":"J. Med. Genet"},{"key":"5769_CR34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/00016480050218681","volume":"120","author":"C Labit-Bouvier","year":"2000","unstructured":"Labit-Bouvier, C. et al. Clinicopathologic Growth Factors in Vestibular Schwannomas: a Morphological and Immunohistochemical Study of 69 Tumours. Acta Otolaryngol. \n                           120, 950\u2013954 (2000).","journal-title":"Acta Otolaryngol."},{"key":"5769_CR35","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2443.2001.00432.x","volume":"6","author":"T Kino","year":"2001","unstructured":"Kino, T. et al. Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma. Genes Cells. \n                           6, 441\u2013554 (2001).","journal-title":"Genes Cells."},{"key":"5769_CR36","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2990.2010.01090.x","volume":"36","author":"PJ Kullar","year":"2010","unstructured":"Kullar, P. J., Pearson, D. M., Malley, D. S., Collins, V. P. & Ichimura, K. CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas. Neuropathol. Appl. Neurobiol. \n                           36, 505\u2013514 (2010).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"5769_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000334968","volume":"74","author":"D Koutsimpelas","year":"2012","unstructured":"Koutsimpelas, D., Ruerup, G., Mann, W. J. & Brieger, J. Lack of neurofibromatosis type 2 gene promoter methylation in sporadic vestibular schwannomas. ORL J. Otorhinolaryngol. Relat. Spec. \n                           74, 33\u201337 (2012).","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"key":"5769_CR38","first-page":"578","volume":"40","author":"JH Lee","year":"1997","unstructured":"Lee, J. H. et al. Reduced Expression of Schwannomin\/Merlin in Human Sporadic Meningiomas. Neurosurgery. \n                           40, 578\u2013587 (1997).","journal-title":"Neurosurgery."},{"key":"5769_CR39","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1373\/clinchem.2014.235457","volume":"61","author":"W Pan","year":"2015","unstructured":"Pan, W., Gu, W., Nagpal, S., Gephart, M. H. & Quake, S. R. Brain Tumor Mutations Detected in Cerebral Spinal Fluid. Clin. Chem. \n                           61, 514\u2013522 (2015).","journal-title":"Clin. Chem."},{"key":"5769_CR40","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1038\/ncomms9839","volume":"6","author":"ML De","year":"2015","unstructured":"De, M. L. et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat. Commun. \n                           6, 8839, doi:10.1038\/ncomms9839 (2015).","journal-title":"Nat. Commun."},{"key":"5769_CR41","doi-asserted-by":"publisher","first-page":"9704","DOI":"10.1073\/pnas.1511694112","volume":"112","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord. Proc. Natl. Acad. Sci. USA \n                           112, 9704\u20139709 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05769-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:42:19Z","timestamp":1671777739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05769-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["5769"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-05769-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]},"assertion":[{"value":"23 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5470"}}